Both in Biotechnology
Moderna vs Amgen
Over the past year MRNA returned +817.1% and AMGN returned +55.7%; their daily moves had a correlation of 0.25.
MRNA +817.1% AMGN +55.7%Growth of $1, one year, split-adjusted
| Metric | MRNA | AMGN |
|---|---|---|
| Price | $228.44 | $461.26 |
| Market cap | $91.20B | $249.37B |
| Today | +3.45% | −0.90% |
| 1 month | +12.4% | +14.5% |
| 6 months | +389.1% | +39.9% |
| Year to date | +674.6% | +40.9% |
| 1 year | +741.1% | +54.6% |
| Revenue growth (YoY) | +2.1% | +9.5% |
| Gross margin | 35.9% | 72.0% |
| Net margin | −539.3% | 23.6% |
| P/E (TTM) | — | 28.5× |
| Price / sales | 40.9× | 6.5× |
| Net cash | $4.54B | -$43.31B |
| Dividend yield | — | 2.19% |
| Volatility (60d) | 230.1% | 33.1% |
| Short % of float | 9.0% | 2.5% |
| Next earnings | Nov 6, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).